Page
Trustees and Officers
Chair's Statement
Trustees, Report
Statement of Trustees, responsibilities
Report of the Independent Examiner............................
Grants awarded
10
11
Statement of Financial Activities
12
Balance sheet
13
CashFlowStatement................-......................
14
Notes to the Finanaal Statements
15-20

Le
al and Administrative iii formaiion
Cha77ty N¢yne
Other by whith the elwrity is knwtLW".
Wessex Meditsl Twi St
Wessexmedicaj R￿arth
Hope for Guernses.
Trust Office
Mailpoint 420
Level B-south Acaaemic Block
Southampton General Hospltal
Southampton
S016 6YD
Registered Charity Number
274839
P8trons and Trustees
Patrons".
The Lords-Lieutenant of Hampshire, Iyiltshire and the Isle of Wisht
The Bailiffs of Guernsey and Jersey
Sir de Vic Carey
Trustees
FrofessoI Sir Charles George
Rotrer Allsopp
Tony Cottam
Professor Max Crispin
Professor Diana Eccles
Luke March
Nid( Page
Chair
Retired 19.04.14
Dean of the Faculty ofmedicine, Uniuersity of Southampton
offi￿rS and Advisers
Indepepzdent Examiner
Sarah Alexander FCCA FCA
Lewis Brownlee (Chidiester) Ltd
Chartered Accountants
Appledram Bams
Birdham Road
Cbichester
West Sussex
P020 7EQ
HonorLVy Solicitors
Womble Bond Dickinson (UK)
Oceana House
ComrneroaA Road
So7Jthampton
S015 IGA

Bimkers
HSBC Bank plc
55 Above Bar Street,
Southampton
S014 7DZ
171vestMent Monagers
M&G Securities Ltd
M&G House
Victoria Road
Chelmsford
CMI IFB
CCLA
Investment Management Limited
One Angel Lane
London
EC4R JAB
Scientific Adviso
Committ
Dr Yihua Wang
Chairniim
Faculty of Environmental and Life Sciences
University of Southampton
Faculty of Medicine, University of Southarnpton
Faculty of Medicine, University of Southampton
Faculty of Medicine, University of Southampton
Faculty of MediciJ)e, University of Southampton
Fawlty of Environrnental and Life Sciences
University of Southampton
Faculty of Envll"onnientsl and Lrfe Scienc
University of Southampton
Faculty of EnvironTnental and Life Saences
University of Southampton
Faculty of Medicine, University of Southampton
Faculty of Medicine, University of Southampton
Faculty of Medicine, Universityr of Southampton
Faculty of Physical Sciences and Engineerin&
University of Southampton
Faculty of Medicine, University of Southampton
Faculty of Physical Sciences and Engineering
University of Southampton
Mr Brian Birch
Dr Jeremy Blaydes
Dr Cornelia Blume
Dr Colleen Deane
Dr Katrin Deinhardt
Dr David Filingeri
Dr Jana Kreppner
Dr Jay Laver
Dr Salah Mansour
Dr Ali Roghanian
Professor Tijia Roose
Professor Jon Strefford
Dr George Williams
External Ex
ert Assessors
Dr James Armstrong
Professor Hilary Critchley
Dr Dario Carugo
University of Bristol
University of Edinburgh
University of (hEoTd

ir's
tatement
.our overallfinancial position
was enhanced by receiptsfrom a
number of legacies and trusts....
JJ
l am pleased to report another successful year for the Trust.
A further, very welcome contribution from the UK Government Covid Medical Research Charity
Support Fund during the year enabled us to offeran additional PhD studentship (for2025) and
to award an extra Innovation Grant in 2024. Our overall financial position was enhanced by
receipts from several legacies and trusts and by the increased retums from investments.
We have continued with what may reasonably be called our 'regular' activities. These include
our annual appearance at the New Forest Show iri July and at ihe University of Southampton's
Science and Engineering Day in March. Given our very limrted workforcè, we are heavily
reliant on the research community to assist us and wts are very grateful fortheir continuing and
positive response.

In April Roger Allsopp retired from the Trustee Board having completed his six year term
a5though sadly,he was prevented by illness from attending re￿nt meetings. Roger had been
the powerhouse of Hope's fund raising operation on the Island of Guemsey. Not only did he
raise our profile there but also he swam the Channel in 2006 to raise funds. He repeated the
challenge in August 2011 at the age of 70 years and 4 months. generated rnore than £350,000
in donations and became the oldest person to achieve that feat. This was recognised by the
presentation of a Points of Light award in 2018, the first to be granted to someone on
Guernsey. Several now distinguished medical researchers are thankTuI forthe efforts of Roger
and his dedicated team of volunteers on Guernseyforthe funding they raised. It is my privilege
to pay tribute to all Roger's activities on behalf of of the Trust and to wish him and his wife
Kaye 811 the very best for the future.
Finally, it is my pleasant duty On￿ again to pay tribute to the donors, fundraisers, partners and
volunteers who have supported the Trust during Ihe past year. It is greatly appreciated by us
Charles George

rustees
This report should be read in conjunction with information shown on paoes 2 and 3 and the Chairnan's
statement on pages 4 to 5.
The Trustees present their report alorig with the Financial Statements of the Trust for ihe year ende
31 De￿Mber 2024. 1 he Financial Statements have been prepored in accordance with rhe accounting
policies set out on page 15 and comply with the trust deed, the Charities Act 2011 and the provisions
of Accounting and Reporting by Chartties: Statement of Recommended practi￿ applicable in the UK
and Republic of Ireland (FRS 102) (effective 1 January 2019)-
Charitable Objècts
Wessex Medical Trust is an unincorporated Trust established by a Declaration of Trust dated
7th November 1977 and subsequent Charity Commission Schemes.
The objects Oi the charity are to fijrther Medical education, medical research and medical practice both
in the Faculty of Medicine and rnore generGlly in the University of Southampton.
The Trustees award grants for the purposes of research into medically-related matters and the
advancement of medical practice and medical education. all for the public benefft. These include the
provision within the University of Southampton OT-.
bursaries and scholarships for students;
teaching facilities and medical equipment Oi all kinds,. and
amenities for ihe students and relevant stafft including any person engaged on
medicaSly-related research or in the instruction of medical students at such hospitsls,
pla￿ of education and other establishments as shall rrom time to time be used for the
instruction of students or the carrying out of medical research.
The Trust considers it fulfils the requirements of charitable purpose and public benefit as set out in the
Chartties Act 2011:
its principal charitable purpose is the advancement of health but IL also contributes
incidentally to the relief of those in need by reason of ill health or disability.
its aims--as set out abov&-are clear and Lhe benefits it creates are directly re12ted to
these aims and OU￿e19h any potential detriment;
the general public are the ultimate beneficiary of the Trust's activities through the
advancement of medica15y-related scien￿. Research paper5 produced as a result OT
each grant made are available in the public domain 8nd the clinical benefits of the
research are, subject to any necessary regulatory approval processes, immediately
available to the general public, both in the Wessex ￿910n and beyond.
Trustees
The Board of Trustees comprises a maximum of twelve elected persons who may seNe for up to Iwo
3-year tems before reiiring. An amendment made to the Trust Deed during 2012 means the Tru•tee
Board now has the power in indtvidual cases to extend a Trustee's ienure beyond six years. The Dean
of the Faculty of Medicine at the Universty of Souihampton is an ex-officio I rustee" the University OT
Southampton may appoint one further person to be a Trustee.
Grants Awarded
Deiails of a51 grants awarded during 2024 are set out on page 11. There was a total of 11 grants
amounting in aggr&g8te to £387.969 and sg applrcants made submissions for one or more of these.
The Trustees are pleasad to report that. On￿ again, the graiits made covered a broad range of diseases
and conditions.

stees
eport, continued
Research Results
The Trust not only has a rigorous process to ensure the qual(ty of the research it supports but it also
has a system of requiring reports on research results. This allows the Trustees to monitor progress
from the fellowships and project grants that they award.
Financial Review
The Trust continues to manage the awarding of grants in accordance with financial circumstances
and keeps fundraising and administrative costs under tight control.
Details of restricted fund movements during the year are set out in Note 16 to the financial statements
and details of grants awarded are on page 11.
The overall financial position of the Trust remains sound.
The Future
The major emphasis continues to be on providing pump prrming grants from the Innovation Fund to
early career researchers. In 2ddition, we have continued to develop the award of PhD studentships,
which is particularly welcomed by the research community.
Governance
The Trust is governed by a Board of Trustees who are each elected for a three year period. A
maximum of knjo consecuts've three year periods may be served after which the Trustee must retire.
Trustees may then tse re-elected after a gap of at least one year unless invited specifically by the
Trustees to continue for a further period which must itself be specified at the outset. An exception is
the Dean of the Faculty of Medicine whose appointment is ex-officio.
The Trustees aim to ensure that the board has a mixture of experience and talents and is
representative of the Wessex region and the Channel Islands. on￿ elected, the Trustees are gtven
full written information about their duties and about the Twst and are invited to have a discussion with
the Trust Director about specific policies and procedures of the time. They are 21so kept up to date
with the Trust's work through attendan￿ at Board Meet'ngs and by ad hoc briefings during the year.
A Trustee induclion pack is given to all new Trustees.
The Board meets at least t￿iCe each year. in the18te spring to re￿1ve and approve the annual accounts
for the previous year, and in the autumn to review the perfonnance of the Trust during the first half year.
In adclition, the Trustees attend to all matters of polw and govemants.
Previously, an Executive Committee, comprising the Chaimian, the Dean, the Trustee with
responsibility for Finance and up to Iwo additional co-opted Trustees, met approximately every three
months with the Trust Director to review progress. Its minutes were circulated to all Trustees. However,
since the closure of the fundraising department in 2016, rt has not been felt iiecessary to hold meetings
of this committee.. nevertheless, its acttvity may be revived if felt necessary by the Trustees.
The Board of Trustees accepts full responsibilty for all of the actiViLies of the Trust and has approved a
comprehensive set of policies and procedures to guide its activities in accordance with current bAst
practice in governance. The Board seeks extemal profession21 advice where it feels this is appropriate.
The Trustee with responsibility for Finance is charged with ensuring thai sufficient controls and
procedures are in pla￿ to protect ihe interests of our donors and of our Trust•es and that the Trust
satisfies the requirements of the Charity Commission, as w-11 as 2dvising the Board on financial matters

ort, con6.nued
incltjding Lhe investment of iÈi funds and on other issues such as a reserves policy. The I rust•es
currently engage CCLA and M&G to atti on their behalf in the investmeni OT funds whilst awaitins
applicaiion. In addition. from time to lime. excess casn may be invested in interest-eaming cash deposit
accounts with CCLA, HSBC, and other major UK banks.
As a Member Oi the Association of Medical Research Charities (AMRC}, the Trust subscribes to a code
of conduci which includes subjecting applications for ￿ndIng to peer review in order that the merit an
likely outcome of the project can be gauged and the 5cientt.fic integrTty of the Drojects being fiJnded by
the Trust ensured. The Trust successfully completed the most receni AMRC peer review audii in 2020.
To maintain this process independently of the Board of Trustees, the Trusi has a Scientinc Advisory
Committee, chaired by a member OT the Faculty of Environmental and Liie ScienTrs at the Universi*
of Southampton. Committee members are lisied on page 3 ond each serves for a maximum three ytsar
tem (with a possible single extension of 3 years) or for the length of their relevant appoinLment at the
University, whichever is shorter. On each occasion. once the Scientific Advisory Committee has
evaluated all applications for a grant for both scientific quality and relevance to the declared priorities
of the appropriate Faculty rrom time to time, a schedule of all applications, together with the 8CtUa
applications for the preferred candidates, will invanably be sent for extemal expert assessment, For
grants of £50,000 and over, all applications are fiJrther sent for fomial extemal peer review, normally by
at least reviewers. Additionally. iniemal peer review may also be soughi.
Once peer review has been satisfactority concluded, the Trustees are invited LO authorise the relevant
granL
Grants are formally awarded by the Trustees on a discrets'onary basis.
Risk Management
The Trustees have instituted a procedure for considering the risks to which the Trust is exposed and
have taken steps to remove or minimise these risks 4vhere they are within their control. In evaluating
these risks, the Trustees have identified the volatility of the stock market as a significant financisl risk.
The procedures in place to mitigate this risk are detailed in the par2graph of this report entitled
'Reserves Policy,. The Trustees have also identified a risk of lack of free reserves.. steps to miLigate
this risk are also set out in the Reserves Policy. Further risk mitigation is achieved by the receipt and
review of regular reports from the investment managers.
Investment Policy
The Trustees have full discretionary investment powers in accordance with the Declaration of Trnst
dated 7th November 1977 under which the Trust was set up. They currently invesL in M&G Charifund
and CCLA COIF Charities Ethical Investrnent Fund vihich are each equity based. In addition, a cash
reserve has been established in the CCLA COIF Charities Deposit Fund. The Trustees keep the
a51ocats.on beiween the funds and cash under regular review to maintsin a balance of risk.
Reserves Policy
It is the policy of the I rust to retain a reserve of £200,000 to protect the Trust from stock markeL volatility.
This policy is kept under review by the Trustees during the year and on prepara￿on Oi the annual
accounts.
Unrestricted Reserves are set out in Note 17 to the accounts.

stees
eport, conbnued
Liquidity
The TrLrstees have set an appropriate reserves policy relating to liquidtty. li is the Trust's policy to keep
sufficient funds in cash or cash equNalents for 12 months, forecast cash oufflow. These ￿sh funds will
provide for grants payments during the year.
Supporters and Advisers
The Board of TrLJStees thanks our honorary solicitors: Womble Bond Dickinson LLP. Tor their assist2nce
during the year. We are also extremely orateful to those external expett. assessors who give their iirne
voluntarily to assist the Scientific Advisory Committee.
Finally we are enormously grateful to all our donors, many of long standing, who have continued to
support our work: without their support the charity could not have achieved so much over recent Ji ears.
Statement of Trustees, Responsibilities
Under charity law. the Trustees are required to prepare financial statemenis for each financial year
which show a true and fair view of the Trusys financial activities during the year and of its financial
position at the end of the year. In preparing those financial statements, generally accepted accounting
practice requires that the Trustees..
select suitsble accounting policies and then apply them consistently,.
observe the methods & principles in the applicable charities SORP.,
make judgements and estimates that are reasonable and prudent.,
state whether the recommendations of applicable Accounting Standards and the
Statement of Recommended Practice.. Accounting and Reporting by Charities
(Charities SORP FRS 102) have been followed, subject to any matertal departures
disclosed and 8xplained in the financial statements:
state whether applicable accounting standards have been followed. subject to any
material departures disclosed and explained in the financial statements," and
prepare the financial statements on the going concem basis unless it is inappropriate
to presume the Trust will continue its activities.
The Trustees are responsible for keeping proper accounting records which disclose with reasonable
accuracy at any time the financial position of the Trust and which enable thom to ensure that the
financial ststements comply with the Charities Act 2011, the Charity (Accounts and Reports)
Regulations 2008 and the provisions of the Trust Deed. They have general responsibility for taking
such steps as are reasonably open to them to safeguard the assets of the Trust and to prevent and
detect fraud and other infringements.
Signed on behalf of the Trustees
Trustee
11 th April 2025

Independent Examinefs Report to the Trustees of
essex ffjfiedical Trust
Independent examinerfs report to the trustees of Wessex Medical Trust
I report to the charity truslees on my examination of the accounts OT Wessex. Medical Trust for the
year ended 31st De￿mber 2024.
Responsibilities and basis of report
As the charity trustees of the Trust you are responsible tr the preparation of the accounts in
accordance with the requirements of the Charities Act L011 (Yhe ACY).
I report in respect of my examination of the Trust's accounts carried out under section 145 of the Attl
and in carying Out my examination I have followed all applicable Directions giv•n by the Charity
Commission under section 145(5)(b) of the Act.
Independent examinerfs statement
I h8ve completed my examination. I confim that no material matters have come to my attention in
connection with the examination giving me cause to believe that in any material respect:
accounts'ng records We￿ not kept in respect of the Trust as required by section 130 of the Act., or
2. the accounts do not accord with those records; or
3. the accounts do not comply wilh the applicable requirements conceming the form and content of
accounts set out in the Charities (Accounts and Reports) Regulations 2008 other than any
requirement that the accounts give a true and fair view which is not a matter considered as part of an
independent examination.
I confirm that there are no other matters to which your attention should be drawn to enable a proper
understanding of the accounts to be reached.
Sarah Alexandear FCCA FCA
Lewis Brownlee (Chichester) Ltd
Chartered Accountants
Appledram Barns
Birdham Road
Chichester
West Sussex
P020 7EQ
Dated t*L)4￿ jl 2(y_) S

GRAtsrrs AWARDED Fog THE PERIOD: 1ST JANUARY 2024_ 31 sr DECEMBER 2024
Grantee
Research Pro
Dr Matthew Blunt
Faculty of Medicine
PhD StudeTrtship
studen￿LUdMIl¥ Horchajova
Sp£tio1 TranscnptomicAn3fysis ofJmm4une cell. Cantsr Celllnt8racbons in
a 3D Lyen7ph Node Model.
Professor Tim Fenton
Faculty of Medicine
PhD Studenlshipiointyfimded Ihe CeNre for Carrer Imrnundogy
S¢udenl-Tsin K¢ay
Est8b/ishing 3D Gulture modelsystems to studyhowinNamm8tion subverts
controlof ￿lI18te duni7g carcinogenests.
Dr Emily Gwyer Findlay
Faculty of Environmental and Lrfe Sciences
PhD Studentshlpj¢intyfunded by R¢8ttrees Trust
s￿0¢￿￿￿11 JohnNon
Investigafyng human Tcelldevelopmentin lymph nodes
Professor Mark Young
Faculty of Engineering and Physical Sciences
PhD Studentshiplointy lundecf a Tcard GTrrrt
StUdeN￿s1ephanie Prfoi
F?frgue nsk m8nag*menlin he3JthL3re." ? wake-up call
3rd Year Medical Student Proje￿ Presenlation Grants
T¢)tsl value
AE01
110,000
AE02
59,880
AE03
53,987.50
AE04
47,014.50
AE05
1,000
AE06
Dr. Triana Amen
Faculty of Environmental & Life Saences
Mo/ecul8rregu18tion 0fper0x￿me fonry8bon andfunctson in Peroxisome
8iogenesis Disorders
Dr Giorgia Chiodin
Faculty of fvledicine
Investigating Ihe GonsequenG&S ofimmJno9/oLSulin v3nable region N-
glycosyla&on in Burkitt/ymphom8 (BL)
Dr Ben Geastra
Faculty of Medicine
The sphingosine- 1-phosph8t& sign8ll1ngp8th￿?Y8n￿OUlcQn1e after
aneurysma15ubar8chnLvdhaemorrh8g8
Dr Camien Jacob
Faculty of Medicine
Haenpolysis in Mul&ple Sclerosys {HIMS)pi7otsrudy
Notawarded
18,124
AE07
18,000
AE08
20,000
AE09
20,000
AE10
AE11
Dr Bonnie Ng
Faculty of Medicine
Usrno single GellRNA sequenung3ndproteomics to unco/ernoveJ
immunotherapeutic tsrgets forimp13ntstiion d￿orde￿.
Dr Nela Nikolic
Faculty of Environmental and Lrfe Sciences
Phage ther8Pyto treat unKFary tractinfecbons
19,973
AE12
19,990
Annual tolal 2024
387,969
Annu&/xots/2023
SYG.347

ststement of Financial Aciivities
Forthe Year Ended 31st December 2024
Note Unrestricted Restricted To'¥al Fund5 Total Funds
Funds
Funds
2024
2023
Income and endowmentsfrom
Donations
Legacies
Other Irdding acliulies
Comd Medical Research Chaiity Support Funds
￿n￿stMent income
2a
14.922
233,000
3,847
199.422
112,544
1,063
15.985
233,ODO
3.847
199,422
112.544
16,552
158,137
3.70a
140,465
100,779
Totsl
563.735
1.063
564,798
419,634
Expenditure on
Raising Funds
Charitable acti￿ltieS
19.512
408,486
19,512
408,486
29,829
318,143
Totsl
427,998
427,998
347,972
Gainsl(l¢ssesl on inKestment assets
$3,145
53,145
26,264
Net incomellexpenditure)
188,882
1.063
97.925
Transfers b&hYeen fijnds
16
43.556
(43,556)
Net movement funds
Reconciliatlon of fvnds
B&lances brought frI￿rd at l January 2024
231438
142,493)
189.945
97,925
1.670.850
76.634 1.747,484 1.849,559
•t
Balances carried fornard at 31 December 2024
1.903,288
34,141 1,937,429 1,747,484
All amounts relate to continuing actlmties.
There were no other Ecogni$ed gains or IDS5es duiing the period.
The notes on pages 16 to 21 foryn part of these financial Statements.

Balance Sheet as at 31 December 2024
Note
2024
2023
Fixed A￿t8
Tangible Assets
Investments
10
2,103,990
1,850.845
2,103,990
1,850,845
Current Assets
Debtors
Short Term Deposits
Cash at bank and in hand
12
75,950
300.000
270,959
586,909
116,169
300,000
48,056
464,225
Current Lia bilitles
AmounLS falling due within one year
13
(369,169)
(272.459}
Net Current As8ets l (Liabilities)
217.740
191,766
Total Assets less Current Liabilities
2.321.730
2,042,611
Lia bilities
Amounts f811ing due after more than one year
14
(384,301)
{295,12n
Net A*ets
15
1,937,429
1,747,484
Funds
Unrestricted
Restricted
General
17
18
1.903,288
34,141
1,670,850
76,634
Totsl Funds
1,937,429
1,747,484
These financial statemenLS were approNed by the Board of Twstees on 1 Ith April 2025 and
were signed on its behalf by
Sir Charles George
Chairman
The notes on pages 15 to 20 fomi p8rt of these financial statements.

Cash Flow Statsmeni
2024
2023
Cash from Operating Activities
Note 1
250.360
102,248
Cash flow from Investing
Purchase of Fixed Asset In￿StMentS
Sale of Fixed Asset Inv2stments
Sale oi Current Asset In*stments
Distributions Recei￿
(200, OC,O)
(100,000)
112,544
100,719
(87,456)
779
Change in cash and cath equivalents in the peri¢)d
162,904
103,027
Cash and cath equivalents at 1st January 2024
348,056
245,029
Cash and cash equivalents at 31st December 2024
510.960
3a.8,056
Note 1
Cash from operating Activltles
Net incomel(expenditure) for reporting period per SOFA
189,945
97,925
Adjustments for.
Distributions reCeI￿d
Decre2sel(incfftse) in Debtors
{Decrease)lincrease in Creditors
{Decrease)/increase in Grants payable
{Gain}ILoss on In￿stMentS
(112.54a.)
40,219
(256)
186.140
(53,1a5)
(100, 779)
23.213
(3,071)
111,225
(26,264)
250,360
102,248

Notesfomiing part of the financt31 ststements
1. Accounting policies
a) The financial statements are prepared undèr the histOriC21 cost Con￿ntion as modtfed by the
revaluation of inNestments at mathet ￿lUe, and are in accordance with Accounting and Reporting by
Chariti&'. Stat8ment of Recommended Practice appticable to ch¢21ities preparing their accounts in
accordance with ¥he Financial RepDrtiro standar￿ 11> and the CharFties Act 20 11.The transition to
FRS102 ha5 had no material effect on the reported ￿nanCIal performance and position of the charity.
b) The restricted funds rep￿ent monies recei* bs. the Trust Ihat is spectfied by the donors for
particular projects. The unrestricted fvnd represents uncommitted ￿nds. The designated fvnds are
unrestrictecl funds that ha* been set aside by the Tnjstees for a sFecific purpose.
cl In￿tr)ents arè stated at Mid￿na￿<et ￿lUe. In￿tments that are separately held to meet
current obligations are treated as cu￿en1 assets. The Statement of Financial Acti￿ltieS includes the
net galns and losses arising on re￿uationS and disposals thrcughout the year.
d) All resources expended, including Irreco￿Trb1e VAT, are charged agairtst income on an accru315
basis. Expenditure is allocated threctly where the costs are directly attributable, otherwise on a
basis of staff usage and their allocation of time. For ftjrther details of expenses, please refer to note
4 of th8 accounts.
Grants payable ar8 payments made to third parties in the fvrtherance of the charitable Objecti￿ of
the Trust. Single or multiwyear grants a￿ acccMJnted for when either the recipient has a reasonable
expectation that they will receiva a grant and the Trustees ha￿ agreed to pay the grant without
condition, or the recipient has a reasonable expectation that they will re¢eiv2 a grant and any
condition attaching to the grant is outside of the control of the Trust. Promsions for grants are made
when the intention to make a grant has ljeen communicated to the reGI￿ent but there is uncertainty
about either the timlng cf the grant or the amount of grant payable.
e) Donations legacies are recognised in the Statement of Financial Actimties only when there is
reasonable assurance of receipt.
Dimdends on i￿trnents and bank interest are accounted for on the ae¢ruals basis.
g) Fixad assets are depreciat&J ow their estimat￿ usefiJl livès. The method ofdepreciating
Flxtures, Fittrngs and Equipment is 33% on cost. All assets costing ovèr £SQO are capitalised.
h) Costs in rEspect of operating leases are charged on a straight line basis o*r the lease tem.
i) Grfts in kind are recognised * matket ￿lue at the date of receipL

Notes Tomiing part tsf the financial ststemeRts- conlinued
2a. Donations
2024
2023
Trusts and foundations
Indiiryduals
Gift aid
Corporate
3.500
12,483
2.350
11,983
2,131
88
15,985
16,552
2b. Legacies
Legacies
233,OC
158,137
At the year end the Trust h&J one outstanding legacy of £70k. vthich needed to be accrued in these
accounts {2023 '. 2 legacies £108K)
At 31 Oecember 2024 the Trust had no notifications of legacies which considered necessary to
ac¢rue12023.' £110k)
3. Invesknent Income
2024
2023
Incorne from UK quoted In￿trnents
Income on short t&TTh deposits and cash
97.519
15.025
90,534
10,245
100,779
Ralsing Funds
Unrestricted Restiicted
2024
2023
E￿nt Costs
Brochures and Lealets
Ad￿rtising
Support Costs
2,979
3,911
722
11.900
19,512
2.979
3,911
722
11,900
19,512
6,641
3,895
708
18,585
29,829
Analysis of ExpendityTE on Charitable Activities
Gra
Funding of
Activities
Support
Costs
Totsl
AdwdncemenL of medical research
387,960
20,526
408,486
387,960
20,526
408,486

Notes fomiing part of the financial *tements- GoTrtinued
6. Allocation of Support Co
Raising
Funds
Charilable
Activities
Totsl
Office Costs
Professional Fees
Independent Examination Fees
1,364
10,536
1.182
16,374
1970
2.546
26,910
2.970
11.900
20,526
32.426
Professional fees (relating to bookkeeping, accountancy and Trust Director) ha￿ b8en
apportioned by the approximate amount of time spent in each area by the professional LO thich the
cost relates.
Office costs hav2 bèen apportioned to the actiiity the cost related to.
7. Stsff Cost5
There were no employees in 2024 {2023:nil)
No remuneration was paid to any Tw$tee in 2024 Q023: ill)
No exp8nses were paid to Trustees in 202412023.. nil)
8. Grants Awarded
During 2024 11 grants totalling £387,969 P023= nine grants tot811ing £310,34n were aw2rded
to the Univèrsity of SoLrthampton to fijnd èducalional posts and ￿Sea￿h projects as detailed on page 11.
Grants not expended totalling £nil (2023.. £43,445) were addedlne**ed against these figures in
the Statement of Financial Actiiities. of these £nil (2023:£nil) ￿￿s from restrtcted ￿nds.
9. Independent Examiners remunerdlion
2024
2023
Independent Examiners SeNces
2,970
2.970
2,850
2,850

Notesfonning part of the financial *tements- continued
10. Tangible Fixed A*ts
Fixture4 Fitting:
and Equipment
Cost at 1 ' January 2024
Additions
Disposals
Cost at 31 December 2024
190
190
Accumulated depreciation at 1 January 2024
Charge ior year
Disposals
Accumulated depreciation at 31 December 2024
190
190
Net Book Value
3131 December 2024
31$t E)ecember 2023
11. Investments at market value: fixed as*ts
Market Value at 1st January 2024
Additions
Disposals
Unre81ised Gain for the year
Realised Loss for the year
Market value at 31st December 2024
1,850,845
200,000
52,145
2. 103,990
st
The histortcal cost of invéstments at 31 December 2024 amounted to £2,027.935
(2023. £1.827,935}
The equities are In￿stMentS held in the M&G Equities Inwestment Fund for charities (Charifijnd)
and the CCLA COIF Charities Ethical I￿￿tment Fund- Income Units

Notes forn?ing part of the linancial statements- Continued
11 Debtors
2024
2023
Other debtors
Prepayments
75,950
116,169
116,169
13. Creditor& amounts falling due within one year
2024
2023
Grants payable
Accruals
362,760
6,409
369, 169
2S5, 794
6,665
272,459
14. Creditors: amountsfalling due after morB than one year
2024
2023
Grants payable
384,301
295,127
295,127
15. Analysis of net assets
Unrestricted Restricted
Funds
Funds
Totsl
Funds
Fixed AsseLS
Current Assèts
Current knabilities
Amounts tslling due after more
than 1 year
Total Net Assets
2,103.990
552,768
1&$9, 169)
2,103,990
586, 909
(369,169)
34,141
384, 301)
1903.288
1384,3011
1, 937.429
34.141

Notesforming part of the financial sktsments- continued
1 S. Restricted Funds
2024
2023
Opening balance at 1 January 2024
Net mopment in restricted fjJnds
Transfer to unresiricled general frjnds
76.634
1,063
143,5561
78,217
11,583)
Balance at31" December 2024
3a., 141
76,634
The income fvnds of the charity include restricted fvnd5 where the donors wish th¢ monies to be
applied in a specffic research are& Tr Twst holds mary diffgrent incomg fvnds and the largest of
these a￿ illustrated teltrN.
The $ums shown are the unexpended balances of donatior6 held on tnjst to be applied for a
specific purpw& by the Trustees at a fvture date.
Owning
Inc¢)rning Rewurces
balance at Re￿UrCeS Expended
Transfers
between
funds
Clo&ng
balancè at
31°
December
2024
January
2024
Are￿ie$
Brain Inlury
Cancer
Cancer ICeNcal3
Diabetes
M8ningitis
ste￿ Mills fijnd
Other disease sP￿1￿C ￿ndS
Total
9,506
9.089
34,271
2.442
135
7,247
11.882
9.S06
19,089)
134,2711
2,442
135
7,247
12.945
1,866
34,141
1195)
143.5561
76,634
The transfers af amounts from ￿$trict￿j ffiJnds teen to the general fjjnd grant5 that relate
to the specific wrpose of the restricted fiJTrJ.
17. Unr8aricted Funds
2024
2023
Opèning balance at l January 2024
Net molement in Free fijnds
Transfer from Reslrieled Fvn¢ls
1,fiO,850
188,882
43,556
1,571.342
99,508
Balance at 31 De￿mber 2024
1,903,288
1,670,850
18. Related Party DI￿o￿r&S
There were no rel*ed party transactions trthe year ended 31 Dewnber 2024